Lipoprotein-associated phospholipase A2 predicts cardiovascular events in dialyzed patients

被引：0
|
作者：
Andreana De Mauri
Matteo Vidali
Doriana Chiarinotti
Giorgio Bellomo
Roberta Rolla
机构：
[1] “Maggiore della Carità” University Hospital,Nephrology and Dialysis Unit
[2] Amedeo Avogadro University of Eastern Piedmont,Department of Health Sciences
[3] “Maggiore della Carità” University Hospital,Clinical Chemistry Laboratory
来源：
Journal of Nephrology | 2019年 / 32卷
关键词：
Lipoprotein-associated phospholipase A2; Cardiovascular disease; Hemodialysis; Mortality; Atherosclerosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：283 / 288
页数：5
相关论文
共 50 条
  • [41] Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease
    Caslake, MJ
    Packard, CJ
    CURRENT OPINION IN LIPIDOLOGY, 2003, 14 (04) : 347 - 352
  • [42] Elevated circulating levels of lipoprotein-associated phospholipase A2 in obese children
    Sakka, Sophia
    Siahanidou, Tania
    Voyatzis, Chronis
    Pervanidou, Panagiota
    Kaminioti, Christina
    Lazopoulou, Natalia
    Kanaka-Gantenbein, Christina
    Chrousos, George P.
    Papassotiriou, Ioannis
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (07) : 1119 - 1125
  • [43] Lipoprotein-associated phospholipase A2 predicted cardiovascular disease in obstructive sleep apnea syndrome
    Xu, Chenyu
    Yu, Fenfang
    Mao, Shan
    Shi, Ying
    Li, Qian
    Fang, Surong
    Tan, Yan
    Gu, Wei
    Ye, Liang
    RESPIRATORY MEDICINE, 2020, 163
  • [44] Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort:: The Cardiovascular Health Study
    Furberg, Curt D.
    Nelson, Jeanenne J.
    Solomon, Cam
    Cushman, Mary
    Jenny, Nancy Swords
    Psaty, Bruce M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (05) : 792 - 799
  • [45] Therapeutic Modulation of Lipoprotein-associated Phospholipase A2 (Lp-PLA2)
    Tselepis, Alexandros D.
    Rizzo, Manfredi
    Goudevenos, Ioannis A.
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (33) : 3656 - 3661
  • [46] Elevated lipoprotein(a) and lipoprotein-associated phospholipase A2 are associated with unfavorable functional outcomes in patients with ischemic stroke
    Jiang, Xue
    Xu, Jie
    Hao, Xiwa
    Xue, Jing
    Li, Ke
    Jin, Aoming
    Lin, Jinxi
    Meng, Xia
    Zheng, Lemin
    Wang, Yongjun
    JOURNAL OF NEUROINFLAMMATION, 2021, 18 (01)
  • [47] Diurnal variation in lipoprotein-associated phospholipase A2 (Lp-PLA2)
    Kaminsky, Leonard A.
    Ozemek, Cemal
    CLINICAL BIOCHEMISTRY, 2012, 45 (09) : 700 - 702
  • [48] Lipoprotein-Associated Phospholipase A2 Is a Risk Factor for Patients With Parkinson's Disease
    Wu, Zubo
    Wu, Suyuan
    Liang, Tao
    Wang, Lin
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [49] Racial variation in lipoprotein-associated phospholipase A2 in older adults
    Lee, Keane K.
    Fortmann, Stephen P.
    Varady, Ann
    Fair, Joan M.
    Go, Alan S.
    Quertermous, Thomas
    Hlatky, Mark A.
    Iribarren, Carlos
    BMC CARDIOVASCULAR DISORDERS, 2011, 11
  • [50] Lipoprotein-Associated Phospholipase A2 Activity and Risk of Recurrent Stroke
    Elkind, Mitchell S. V.
    Tai, Wanling
    Coates, Kristen
    Paik, Myunghee C.
    Sacco, Ralph L.
    CEREBROVASCULAR DISEASES, 2009, 27 (01) : 42 - 50
12345